PER
Click for more information
6.90% 8.1¢ percheron therapeutics limited

Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK, page-8

  1. arjay
    3,539 Posts.
    lightbulb Created with Sketch. 769
    clock Created with Sketch.
    27/06/23
    15:59
    Post #: 68494888
    Very happy...absolutely fantastic...well done CG and all holders....patience will be rewarded....

    EU is a huge market...and we all know Sarepta is not allowed to sell in EU...

    If they are interested ....yes with a few hundred million we may think about a deal if CG is in a good mood...lol

    Go ANP....
    ANP Price at posting: 6.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 21  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.006(6.90%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.7¢ 8.7¢ 8.1¢ $154.2K 1.820M

Buyers (Bids)

No. Vol. Price($)
2 33824 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 275242 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.